R. Young - May 14, 2021 Form 4 Insider Report for CEL SCI CORP (CVM)

Role
Director
Signature
Peter Young
Stock symbol
CVM
Transactions as of
May 14, 2021
Transactions value $
$1,280
Form type
4
Date filed
5/17/2021, 05:29 PM
Next filing
Jun 29, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVM Options Award $1.28K +128K +30.84% $0.01* 543K May 14, 2021 Common Stock 128K $20.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day. None of the options will be exercisable before May 13, 2022.